Today, Thanos Stavropoulos from CERTH, talked about Mobile and Wearable devices for Digital Biomarkers detection and collection, showing RADAR-AD project.

What is RADAR-AD and what is its mission?

(Remote Assessment of Disease and Relapse – Alzheimer’s Disease) aims to identify biosignatures indicative of functional decline in early Alzheimer’s Disease (AD) by using remote monitoring techniques. The goal is to do so by exploring how mobile technologies – such as smart phones, wearables, and home-based sensors – can measure disability progression associated with AD with greater sensitivity than currently used methods, such as direct observation or caregiver recall.

The RADAR-AD main goal is highly complementary with LETHE project, and we envisage a constructive and productive collaboration in the dementia monitoring European ecosystem.

Skip to content